101 related articles for article (PubMed ID: 9829566)
1. Abnormality of myocardial oxidative metabolism in noninsulin-dependent diabetes mellitus.
Hattori N; Tamaki N; Kudoh T; Masuda I; Magata Y; Kitano H; Inubushi M; Tadamura E; Nakao K; Konishi J
J Nucl Med; 1998 Nov; 39(11):1835-40. PubMed ID: 9829566
[TBL] [Abstract][Full Text] [Related]
2. Assessment of myocardial oxidative metabolic reserve with positron emission tomography and carbon-11 acetate.
Henes CG; Bergmann SR; Walsh MN; Sobel BE; Geltman EM
J Nucl Med; 1989 Sep; 30(9):1489-99. PubMed ID: 2788722
[TBL] [Abstract][Full Text] [Related]
3. Oxidative metabolism in the myocardium in normal subjects during dobutamine infusion.
Tamaki N; Magata Y; Takahashi N; Kawamoto M; Torizuka T; Yonekura Y; Tadamura E; Okuda K; Ono S; Nohara R
Eur J Nucl Med; 1993 Mar; 20(3):231-7. PubMed ID: 8462612
[TBL] [Abstract][Full Text] [Related]
4. Myocardial oxidative metabolism in hyperthyroid patients assessed by PET with carbon-11-acetate.
Torizuka T; Tamaki N; Kasagi K; Misaki T; Kawamoto M; Tadamura E; Magata Y; Yonekura Y; Mori T; Konishi J
J Nucl Med; 1995 Nov; 36(11):1981-6. PubMed ID: 7472585
[TBL] [Abstract][Full Text] [Related]
5. Myocardial oxidative metabolism in remote normal regions in the left ventricles with remodeling after myocardial infarction: effect of beta-adrenoceptor blockers.
Ohte N; Kurokawa K; Iida A; Narita H; Akita S; Yajima K; Miyabe H; Hayano J; Kimura G
J Nucl Med; 2002 Jun; 43(6):780-5. PubMed ID: 12050323
[TBL] [Abstract][Full Text] [Related]
6. Myocardial oxidative metabolism in normal subjects in fasting, glucose loading and dobutamine infusion states.
Tamaki N; Magata Y; Takahashi N; Kawamoto M; Torizuka T; Yonekura Y; Nishizawa S; Sadato N; Tadamura E; Ono S
Ann Nucl Med; 1992 Nov; 6(4):221-8. PubMed ID: 1489631
[TBL] [Abstract][Full Text] [Related]
7. Organ-specific insulin resistance in patients with noninsulin-dependent diabetes mellitus and hypertension.
Yokoyama I; Ohtake T; Momomura S; Yonekura K; Yamada N; Nishikawa J; Sasaki Y; Omata M
J Nucl Med; 1998 May; 39(5):884-9. PubMed ID: 9591594
[TBL] [Abstract][Full Text] [Related]
8. [Assessment of myocardial metabolic reserve with positron emission tomography and C-11 acetate].
Ono S; Nohara R; Kambara H; Okuda K; Mohiuddin IH; Tamaki N; Konishi J
J Cardiol; 1993; 23(4):365-70. PubMed ID: 8064586
[TBL] [Abstract][Full Text] [Related]
9. Regional myocardial oxygen consumption determined noninvasively in humans with [1-11C]acetate and dynamic positron tomography.
Armbrecht JJ; Buxton DB; Brunken RC; Phelps ME; Schelbert HR
Circulation; 1989 Oct; 80(4):863-72. PubMed ID: 2791250
[TBL] [Abstract][Full Text] [Related]
10. Feasibility of planar myocardial carbon 11-acetate imaging.
Klein LJ; Visser FC; Nurmohamed SA; Vink A; Peters JH; Knaapen P; Kruijer PS; Herscheid JD; Teule GJ; Visser CA
J Nucl Cardiol; 2000; 7(3):221-7. PubMed ID: 10888392
[TBL] [Abstract][Full Text] [Related]
11. Use of [11C]acetate and [15O]O2 PET for the assessment of myocardial oxygen utilization in patients with chronic myocardial infarction.
Ukkonen H; Knuuti J; Katoh C; Iida H; Sipilä H; Lehikoinen P; Någren K; Voipio-Pulkki LM
Eur J Nucl Med; 2001 Mar; 28(3):334-9. PubMed ID: 11315601
[TBL] [Abstract][Full Text] [Related]
12. Myocardial glucose metabolism in noninsulin-dependent diabetes mellitus patients evaluated by FDG-PET.
Ohtake T; Yokoyama I; Watanabe T; Momose T; Serezawa T; Nishikawa J; Sasaki Y
J Nucl Med; 1995 Mar; 36(3):456-63. PubMed ID: 7884509
[TBL] [Abstract][Full Text] [Related]
13. Noninvasive determination of myocardial blood flow, oxygen consumption and efficiency in normal humans by carbon-11 acetate positron emission tomography imaging.
Porenta G; Cherry S; Czernin J; Brunken R; Kuhle W; Hashimoto T; Schelbert HR
Eur J Nucl Med; 1999 Nov; 26(11):1465-74. PubMed ID: 10552089
[TBL] [Abstract][Full Text] [Related]
14. Abnormal myocardial kinetics of 123I-heptadecanoic acid in subjects with impaired glucose tolerance.
Turpeinen AK; Kuikka JT; Vanninen E; Uusitupa MI
Diabetologia; 1997 May; 40(5):541-9. PubMed ID: 9165222
[TBL] [Abstract][Full Text] [Related]
15. Myocardial oxidative metabolic supply-demand relationships in patients with nonischemic dilated cardiomyopathy.
Kronenberg MW; Cohen GI; Leonen MF; Mladsi TA; Di Carli MF
J Nucl Cardiol; 2006 Jul; 13(4):544-53. PubMed ID: 16919578
[TBL] [Abstract][Full Text] [Related]
16. PET imaging of oxidative metabolism abnormalities in sympathetically denervated canine myocardium.
Hutchins GD; Chen T; Carlson KA; Fain RL; Winkle W; Vavrek T; Mock BH; Zipes DP
J Nucl Med; 1999 May; 40(5):846-53. PubMed ID: 10319760
[TBL] [Abstract][Full Text] [Related]
17. Impairment of BMIPP uptake precedes abnormalities in oxygen and glucose metabolism in hypertrophic cardiomyopathy.
Tadamura E; Kudoh T; Hattori N; Inubushi M; Magata Y; Konishi J; Matsumori A; Nohara R; Sasayama S; Yoshibayashi M; Tamaki N
J Nucl Med; 1998 Mar; 39(3):390-6. PubMed ID: 9529280
[TBL] [Abstract][Full Text] [Related]
18. Myocardial tissue and metabolism characterization in men with alcohol consumption by cardiovascular magnetic resonance and 11C-acetate PET/CT.
Liu S; Lin X; Shi X; Fang L; Huo L; Shang F; Knuuti J; Han C; Wu X; Guo R; Ding H; Zhang R; Duan H; Ding J; Xing H; Zhao X
J Cardiovasc Magn Reson; 2020 Apr; 22(1):23. PubMed ID: 32299425
[TBL] [Abstract][Full Text] [Related]
19. [11C-acetate PET--evaluation of regional cardiac oxidative metabolism].
Nohara R
Nihon Rinsho; 1994 Jul; 52 Suppl(Pt 1):622-8. PubMed ID: 12436592
[No Abstract] [Full Text] [Related]
20. Measurement of myocardial blood flow with PET using 1-11C-acetate.
Sciacca RR; Akinboboye O; Chou RL; Epstein S; Bergmann SR
J Nucl Med; 2001 Jan; 42(1):63-70. PubMed ID: 11197982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
